Lung Cancer News

Pembrolizumab extended DFS compared with placebo as adjuvant treatment for patients with stage IB to stage IIIA non-small cell lung cancer, according to topline data released by the agent’s manufacturer.

The FDA granted breakthrough therapy designation to telisotuzumab vedotin for treatment of certain patients with non-small cell lung cancer.

The FDA granted breakthrough therapy designation to CLN-081 for treatment of certain patients with non-small cell lung cancer.

Quitting smoking at or around time of diagnosis conferred a significant survival benefit for patients with lung cancer, according to results of a meta-analysis published in Journal of Thoracic Oncology.

The FDA granted breakthrough therapy designation to patritumab deruxtecan for treatment of certain patients with non-small cell lung cancer.

People with a smoking history who quit, especially at younger ages, avoid much of the excess risk for dying of cancer associated with continued smoking, according to a prospective study published in JAMA Oncology.

Studies that have found a link between smoking and COVID-19 severity provide a new reason for primary care physicians to keep talking to their patients about ways to quit smoking, an expert told Healio.

Karen L. Kelly, MD, has been appointed CEO of International Association for the Study of Lung Cancer.

Healio presents highlights from the virtual CHEST Annual Meeting, which was held Oct. 17 to 20.

Stereotactic ablative radiotherapy appeared as effective as surgery among patients with operable early-stage non-small cell lung cancer, according to results published in The Lancet Oncology.